empty spacer image empty spacer image empty spacer image empty spacer image empty spacer image empty spacer image empty spacer image
Ladiges Lab Header empty spacer image
main link lab link research link news & events link current funding link resources link empty spacer image
small menu empty spacer image
Current Funding Header
Comparative Mouse Genomics Center  
U01 ES11045
Principle Investigator:
W.C. Ladiges
Funding Agency:
Dates of Funding
04/01/01-03/31/07

 

One of five centers across the U.S. collaborating to develop mouse models for studying the biological function of environmentally sensitive DNA repair/cell cycle control gene variants in the human population, and establishing a genetically engineered mouse system as a mammalian model for human functional genomics and single nucleotide polymorphism variant-environment interactions.

 

Nathan Shock Center of Excellence in Basic Biology of Aging

P30 AG13280
Principle Investigator:
P.S. Rabinovitch
Funding Agency:

NIH / National Institute on Aging

Core PI:
W. C. Ladiges
Dates of Funding:

07/01/05 - 06/30/10

 

Ladiges is director of Resource Core A, a program for transgenic animal model development providing state-of-the-art technology for the development of genetically altered rodents in order to advance knowledge about the basic biology of aging.

 

Center for Ecogenetics and Environmental Health   
               P30 ES07033
Principle Investigator:
D. Eaton
Core PI:

W.C. Ladiges

Funding Agency:
Dates of Funding:

04/01/05 – 03/31/10

 

Ladiges is director of Resource Core 4, a program providing transgenic animal support for the development of new rodent models evaluating gene action in response to environmental influences.

 

Gene Action in the Pathobiology of Aging     
            P30 AG01751
Principle Investigator:
P.S. Rabinovitch
Core PI:

W.C. Ladiges

Funding Agency:
Dates of Funding:

10/01/03 – 09/30/08

 

This program project aims to provide a vehicle for a highly integrated series of investigations designed to test theories of aging that emphasize a major role for oxidative damage to DNA, especially mitochondrial DNA, and with an emphasis on the use of genetically altered mice.

 

Genetic Instability in Werner Syndrome
 P01 CA77852
Principle Investigator:
R. J. Monnat
Core PI:
Ladiges
Funding Agency:
Funding Dates:
07/01/04 – 06/30/09

 

Ladiges is leader of Core B, a resource designed to provide animal breeding, maintenance, and phenotyping resources for program research projects and cores with a focus on the WRN gene, genomic instability, and tumorigeneis.

 

The FHCRC/UW Toxicogenomics Consortium  
U19 ES11387
Principle Investigator:
Zarbl
Funding Agency:

NIH/National Institute of Environmental Health Sciences

Dates of Funding:
10/01/01-09/30/06

 

The overall aim is to describe global gene expression profiles for wild-type and transgenic mice and rats and human cell lines exposed to a variety of environmentally-relevant xenobiotics.

 

DNA replication fidelity and cancer
    R01 CA098243
Principle Investigator:
B. Preston
Co-Investigator:
W.C. Ladiges
Funding Agency:
Funding Dates:
04/01/04-03/30/09

 

The overall goal of this project is to characterize the role of DNA polymerase delta proof-reading in the maintenance of genetic stability and avoidance of disease. The specific aims are to characterize the mutator phenotype of pol delta exo minus cells and mice, and to examine cooperativity of pol delta with mismatch repair.

 

Regulating Longevity    
              
Principle Investigator:
Kennedy and Rabinovitch
Core PI:

W.C. Ladiges

Funding Agency:
Ellison Medical Foundation
Dates of Funding:

01/01/05 - 12/31/09

 

A consortium for the determination of public pathways regulating longevity
This consortium will establish an exceptional infrastructure for research into the genetic regulation of aging: a systematic library of yeast strains, worm models and mouse strains and associated databases that will be available to all aging researchers. These will represent a unique resource for study of the genetic elements and pathways whose down-regulation may extend lifespan and health span.

 

Alzheimer’s disease and impaired APP proteolysis   
               R21 AG26476
Principle Investigator:
W.C. Ladiges
Co-Investigator:

J.C. Wiley

Funding Agency:
NIH / NIA
Dates of Funding:

09/01/05 - 08/31/07

 

Alzheimer’s disease and impaired APP proteolysis
The goal of this proposal is to study the effects of familial Alzheimer’s disease mutations on the gamma-secretase mediated cleavage of APP in the brains of mice using a transgenic reporter mouse model.

 

 

link to UW link to CMGC link to ecogenetics link to trangenic resources link to nathan shock center

 

link to UW link to CMGC link to ecogenetics link to trangenic resources link to nathan shock center